‘Amazing’ new lung cancer treatment 40% more effective than standard amid ‘golden age’ of cancer research
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...
Cancer drug resistance causes and categories identified
Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four main categories and highlighting possible new therapeutic targets.
FiercePharma3d
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche's Tecentriq
Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...
Crain's Chicago Business4d
AbbVie tries to fast-track new cancer drug for approval to join 2 others in its pipeline
There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...
medtechdive7h
Novocure wins FDA approval for electric field device in lung cancer
Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.
"It's Amazing": New Lung Cancer Treatment Shows 40% Improved Efficacy
"Survival rates for lung cancer are still very low compared with other types of the disease and so to see such positive ...
Business Wire3d
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...
Yahoo13d
‘Amazing’ new lung cancer treatment 40% more effective than standard amid ‘golden age’ of cancer research
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for over 40% longer than previously possible, a wide-ranging trial funded by ...